We are live on
!
Find out more
EPRS
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
EPRS
Delisted
EPRS was delisted on the 3rd of August, 2016.
37 hedge funds and large institutions have $34.8M invested in EPIRUS BIOPHARMACEUTICALS INC COM in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
16% less capital invested
Capital invested by funds: $41.3M → $34.8M (-$6.45M)
18% less funds holding
Funds holding: 45 → 37 (-8)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Holders
37
Holders Change
-8
Holders Change %
-17.78%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
9
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
B
Bailard
Foster City,
California
|
+$1.6M |
| 2 |
SM
Southport Management
Wilson,
Wyoming
|
+$70.2K |
| 3 |
Jennison Associates
New York
|
+$42.9K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$41.9K |
| 5 |
Bank of New York Mellon
New York
|
+$39.9K |
